Skip Navigation

Journal of Intellectual Property Law & Practice 2008 3(4):206-208; doi:10.1093/jiplp/jpn037
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press. All rights reserved

JIPLP Express

JIPLP Express

A rapid-read overview of the main items in this issue

The first 10% of the full text of this article appears below.


   Current intelligence
 
Patents
Advanced therapies and the outer limits of DNA regulation: new horizons for patents or a scaffold too far? This Regulation seeks to regulate existing and future advanced therapy medicinal products intended for the market in Member States, being either prepared industrially or manufactured by a method involving an industrial process, and introduces additional provisions to those laid down in the pharmaceutical legislation Directive 2001/83. (p. 210)

Federal Circuit affirms Nilssen's 15 patents unenforceable for inequitable conduct. The US Federal Circuit affirmed the District Court finding; it did not abuse its discretion in holding 15 of Nilssen's patents unenforceable due to his intentional withholding of material information during patent prosecution from the US Patent Office (‘USPTO’). (p. 212)

Trade marks
Court in Argentina holds that HARRODS trade marks cannot co-exist. In October 2007, Chamber I of the Federal Civil and Commercial Chamber of Appeals, Buenos . . . [Full Text of this Article]

Copyright
Personality rights and publicity rights

   Practice point
 
Managing generic competition and patent strategies in the pharmaceutical industry (p. 226)

   Articles
 
‘Innocent infringement’ and the Community unregistered design right: the position in the UK and Ireland (p. 236)
Sealing the cracks: a proposal to update the anti-cybersquatting regime to combat advertising-based cybersquatting (p. 246)
Swiss trade marks practice on misleading geographical indications (p. 262)

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?